Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

BAX

Baxter Intl

NYSE

Real-time Quotes | Nasdaq Last Sale

78.28

+0.22

+0.28%

After Hours: 78.28 0 0.00% 16:00 03/08 EST

OPEN

78.21

PREV CLOSE

78.06

HIGH

79.30

LOW

77.65

VOLUME

1.55M

TURNOVER

52 WEEK HIGH

95.19

52 WEEK LOW

69.10

MARKET CAP

39.53B

P/E (TTM)

36.72

Baxter International Inc. stock rises Monday, outperforms market

Shares of Baxter International Inc. inched 0.28% higher to $78.28 Monday, on what proved to be an all-around mixed trading session for the stock market, with...

marketwatch.com · 4h ago

Globa Patient Monitoring Devices Market Research Report 2020 Market Size, Share, Value, and Competitive Landscape forecast year

Mar 08, 2021 (Heraldkeepers) -- Patient Monitoring Devices Market: Market Segments: By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring,...

Heraldkeepers · 7h ago

Moderna ropes in Baxter for fill/finish manufacturing of COVID-19 vaccine

Baxter International ([[BAX]] +0.9%) has agreed to provide fill/finish sterile manufacturing services and supply packaging for ~60-90M doses of the COVID-19 vaccine developed Moderna ([[MRNA]] -3.5%).The production planned for 2021 will take

Seekingalpha · 8h ago

Burn Care Products & Accessories Market Share, Development by Companies Outlook, Growth Prospects and Key Opportunities by 2030

Mar 08, 2021 (Heraldkeepers) -- The global Burn Care Products & Accessories market report provides geographic analysis covering regions, such as North...

Heraldkeepers · 9h ago

Cancer Immunomodulator Market Size, Share & Trends Analysis Report With Growth Forecast 2020-2027

Mar 08, 2021 (Heraldkeepers) -- Market Research Engine has published a new report titled as "Cancer Immunomodulator Market Size By Product (Method of Use:...

Heraldkeepers · 9h ago

Blood Testing Market Share, Size, Trends, Industry Analysis to 2027 by Disease Type; By Technology; By Specialty; By End-Use; By Regions

Mar 08, 2021 (Heraldkeepers) -- The Blood Testing Market is expected to exceed more than US$ 60.8 Billion by 2024 at a CAGR of 2.5% in the given forecast...

Heraldkeepers · 9h ago

Moderna Signs Vial-Filling Deal With Baxter to Bolster Supply

Moderna Inc. added a second partner in the U.S. to help fill vaccine vials, inking a deal with Baxter International Inc. to help the company produce 60 million to 90 million Covid vaccine doses in 2021.

Bloomberg · 10h ago

Baxter To Offer Fill/Finish Services To Moderna's COVID-19 Vaccine In US

Benzinga · 11h ago

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of BAX. Analyze the recent business situations of Baxter Intl through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BAX stock price target is 92.18 with a high estimate of 105.00 and a low estimate of 80.00.

EPS

Institutional Holdings

Institutions: 1.60K

Institutional Holdings: 453.37M

% Owned: 89.76%

Shares Outstanding: 505.10M

TypeInstitutionsShares

Increased

323

37.07M

New

194

-2.70M

Decreased

399

37.26M

Sold Out

Performance
Asset Allocation
Dividend History

No Data

Industry

Medical Equipment, Supplies & Distribution

-0.72%

Healthcare Equipment & Supplies

-1.34%

Key Executives

Chairman/President/Chief Executive Officer/Director

Jose Almeida

Chief Financial Officer/Executive Vice President

James Saccaro

Senior Vice President/Chief Accounting Officer/Controller

Brian Stevens

Senior Vice President/General Counsel

Sean Martin

Senior Vice President/Director of Human Resources

Jeanne Mason

Senior Vice President

Giuseppe Accogli

Senior Vice President

Cristiano Franzi

Senior Vice President

Andrew Frye

Senior Vice President

Jacqueline Kunzler

Lead Director/Independent Director

Albert Stroucken

Director

David Wilkes

Independent Director

Thomas Chen

Independent Director

John Forsyth

Independent Director

James Gavin

Independent Director

Peter Hellman

Independent Director

Michael Mahoney

Independent Director

Patricia Morrison

Independent Director

Stephen Oesterle

Independent Director

Cathy Smith

Independent Director

Thomas Stallkamp

Independent Director

Amy Wendell

Declaration Date Dividend Per Share Ex-Div Date: 02/16/2021
Dividend USD 0.245
02/25/2021; 11/16/2020
Dividend USD 0.245
12/03/2020; 07/14/2020
Dividend USD 0.245
08/28/2020; 05/05/2020
Dividend USD 0.245
06/04/2020; 02/18/2020
Dividend USD 0.22
02/27/2020; 11/19/2019
Dividend USD 0.22
12/05/2019; 07/16/2019
Dividend USD 0.22
08/29/2019; 05/07/2019
Dividend USD 0.22
06/06/2019; 02/19/2019
Dividend USD 0.19
02/28/2019; 11/13/2018
Dividend USD 0.19
11/30/2018; 07/17/2018
Dividend USD 0.19
08/30/2018; 05/08/2018
Dividend USD 0.19
05/31/2018; 02/20/2018
Dividend USD 0.16
03/01/2018; 11/14/2017
Dividend USD 0.16
11/30/2017; 07/18/2017
Dividend USD 0.16
08/30/2017; 05/02/2017
Dividend USD 0.16
05/31/2017; 02/21/2017
Dividend USD 0.13
03/01/2017; 11/08/2016
Dividend USD 0.13
11/30/2016; 07/19/2016
Dividend USD 0.13
08/31/2016; 05/03/2016
Dividend USD 0.13
06/01/2016; 02/16/2016
Dividend USD 0.115
03/02/2016; 11/10/2015
Dividend USD 0.115
12/02/2015; 07/30/2015
Dividend USD 0.115
09/02/2015; 05/05/2015
Dividend USD 0.52
05/28/2015; 02/17/2015
Dividend USD 0.52
03/09/2015; 11/11/2014
Dividend USD 0.52
12/03/2014; 07/22/2014
Dividend USD 0.52
09/03/2014; 05/05/2014
Dividend USD 0.52
06/04/2014; 02/18/2014
Dividend USD 0.49
03/05/2014; 11/12/2013
Dividend USD 0.49
12/04/2013; 07/24/2013
Dividend USD 0.49
09/04/2013

All
Financials
Insiders

About BAX

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

Webull offers kinds of Baxter International Inc stock information, including NYSE:BAX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BAX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BAX stock methods without spending real money on the virtual paper trading platform.